Philippe Souque
Paris, 75015, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Lentiviral vector-based T-cell vaccines against Zika and yellow fever viruses.
Journal: Vaccine
Published: April 23, 2025
Preclinical proof of concept of a tetravalent lentiviral T-cell vaccine against dengue viruses.
Journal: Frontiers in immunology
Published: April 18, 2023
A lentiviral vector expressing a dendritic cell-targeting multimer induces mucosal anti-mycobacterial CD4+ T-cell immunity.
Journal: Mucosal immunology
Published: October 21, 2021
A lentiviral vector encoding fusion of light invariant chain and mycobacterial antigens induces protective CD4+ T cell immunity.
Journal: Cell reports
Published: June 10, 2021
Brain cross-protection against SARS-CoV-2 variants by a lentiviral vaccine in new transgenic mice.
Journal: EMBO molecular medicine
Published: April 22, 2021
First immunotherapeutic CAR-T cells against the immune checkpoint protein HLA-G.
Journal: Journal for immunotherapy of cancer
Published: February 15, 2021
High seroprevalence but short-lived immune response to SARS-CoV-2 infection in Paris.
Journal: European journal of immunology
Published: November 07, 2020
Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models.
Journal: Cell host & microbe
Published: September 08, 2020
Lentiviral vector induces high-quality memory T cells via dendritic cells transduction.
Journal: Communications biology
Published: July 06, 2020
A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations.
Journal: Science translational medicine
Published: April 18, 2020
Clustering and reverse transcription of HIV-1 genomes in nuclear niches of macrophages.
Journal: The EMBO journal
Published: April 09, 2020
Last Updated: 09/26/2026